Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 04/22/2022
Closing price: 62.25
Support price level: | N/A |
Resistance price level: | $63.59 |
Relative strength index (14-day RSI) | 63.3 |
Beta | 0.34 |
- The price of this low-beta stock is expected to increase by 0.34% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- GILD is below its 200-day moving average - additional caution warranted in long positions.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$57.92 | $73.64 | 30.0% |
200 day | 50 day | 20 day | 10 day |
$67.25 | $60.58 | $61.16 | $62.37 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
25.7% | 20.9% | 22.6% | 24.1% |
- 6.1% in the next week.
- 13.7% in the next month.
- 38.7% in the next year.
Company news for Gilead Sciences Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks